Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 2, Episode 16: Breaking Barriers with Jacob Becraft
Join Michael Pietrack on the Pharmaverse Podcast as he interviews Jake Becraft, CEO & Co-founder of Strand Therapeutics! Discover how Jake is transforming cancer treatment with programmable mRNA therapies.
Hear about his journey from a small town in Illinois to MIT, how jiu-jitsu shaped his leadership, and the lessons of team-building, failure, and innovation. Learn about Strand’s breakthroughs, including the game-changing abscopal response, and the mindset needed to challenge scientific dogma.
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Thakur, Sayanta & Lahiry, Sandeep
Accelerated drug approvals in oncology: Pros and cons
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
Article
Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD